A systematic review and meta-analysis published in Diabetes, Obesity and Metabolism examined inflammatory markers across multiple GLP-1 receptor agonist trials and found reductions in hs-CRP levels, though the magnitude and clinical significance of these changes varied across studies
This prolonged transit allows excessive water absorption, resulting in harder, drier stools that are more difficult to pass
The most commonly reported adverse events (AEs) were mild to moderate gastrointestinal-related AEs, consistent with the known safety profile of GLP-1 receptor agonists
Energy Levels MICC injections can increase energy levels, which can be helpful for people who are fatigued or involved in strenuous physical activities
Poor sleep can undo a lot of progress, including weight gain
laboratory (HPLC with UV detection and mass spectrometry)